Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002695 · ClinicalTrials.gov registry record
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
A clinical trial, sponsored by ECOG-ACRIN Cancer Research Group.
- Completed
- Registry status
- 530
- Enrollment target
NCT00002695 is a clinical trial that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 530 participants.
The verdict
NCT00002695 has completed, sponsored by ECOG-ACRIN Cancer Research Group.
- COMPLETED
- Registry status
- 530 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as analysis of tumor tissue and lymph nodes that have been surgically removed, may improve the treatment of patients with cancers of the head and neck. PURPOSE: Diagnostic trial to determine if analyzing tumor tissue and lymph nodes surgically removed from patients with cancers of the head and neck can predict recurrence of the cancer.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC mutation analysis
- GENETIC DNA stability analysis
- GENETIC microsatellite instability analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 1996-04-30 |
| Est. Completion | 2011-05-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002695
The ClinicalTrials.gov registry entry for NCT00002695 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 530 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00002695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002695 about?
NCT00002695 is a clinical study titled "Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck". RATIONALE: Diagnostic procedures, such as analysis of tumor tissue and lymph nodes that have been surgically removed, may improve the treatment of patients with cancers of the head and neck. PURPOSE: Diagnostic trial to determine if analyzing tumor tissue and lymph nodes surgically removed from pat...
What is the current status of trial NCT00002695?
This trial is currently completed. The enrollment target is 530 participants. The study started on 1996-04-30. Estimated completion is 2011-05-27.
What interventions are being tested in trial NCT00002695?
The interventions under investigation include: laboratory biomarker analysis (OTHER), mutation analysis (GENETIC), DNA stability analysis (GENETIC), microsatellite instability analysis (GENETIC).
Who is sponsoring clinical trial NCT00002695?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.